StockData
Kyverna Therapeutics, Inc. logo

Kyverna Therapeutics, Inc. (KYTX) stock

KYTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$4.48−0.22 (-4.68%)

Close on Nov 18, 2026Market cap $277.06MP/E –Yield –

Kyverna Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Kyverna Therapeutics's market cap was $315.24M on Nov 11, 2026, against $335.90M a year earlier. Over the last 3 years it ranged from $18.93M to $540.23M, with a median of $315.24M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$315.24M-23.4%
2025Dec 31, 2025$411.66M+155.0%
2024Dec 31, 2024$161.45M–

More Kyverna Therapeutics figures

See a number that looks wrong?